Heart and blood pressure
Piperineand Systolic blood pressure
Both sources here measured lower systolic blood pressure.
How sure anyone can be
Low certainty, level 2 of 4Further research is likely to change this.
The most certain of the two findings here; each record carries its own.
The numbers reported
No number has been put on this yet. Two sources recorded only which way the numbers went — for now, that is all we have here.
Two sources, newest first
What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.
Randomised trial, 2023
Low certainty, level 2 of 4Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial.
Phytother Res. 2023;37(6):2217-2229. doi:10.1002/ptr.7764. PMID:36799355.
- Number reported
- Not in the abstract
- Which way it went
- Lower
- Likely range
- Not in the abstract
- Source’s own words
- no effect size is reported: the abstract gives only a p value for the between-group comparison, with no magnitude or interval
- Who was studied
- Adult with NAFLD
- Compared with
- placebo
- Amount taken
- 5 mg/day piperine (with 500 mg/day curcumin)
- For how long
- 84 days
- Disagreement between studies
- Not in the abstract
- Kind of record
- Journal article
How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
- Starts at High
- Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
- Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
- Ends at Low2 steps down.
- Checked, nothing to step it down for
- indirectness
- Inconsistency
- One study, so there was nothing to disagree
Imprecision stops at the first check that applies; others may apply too.
AI-reviewed & signed — an AI agent re-read this finding against the saved source and checked that the quote, the numbers, the units and the direction match it. No person read it. The owner authorised the agent to sign the batch with the owner's key, and every build rechecks that signature against these exact bytes.
Randomised trial, 2023 · 66 participants
Low certainty, level 2 of 4The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: a randomized controlled trial.
Nutr J. 2023;22(1):69. doi:10.1186/s12937-023-00905-1. PMID:38082237.
- Number reported
- Not in the abstract
- Which way it went
- Lower
- Likely range
- Not in the abstract
- Source’s own words
- no effect size is reported: the abstract gives only a p value for the between-group comparison, with no magnitude or interval
- Who was studied
- Adult with ischemic stroke in rehabilitation
- Compared with
- placebo
- Amount taken
- 5 mg/day piperine (with 500 mg/day curcumin)
- For how long
- 84 days
- Disagreement between studies
- Not in the abstract
- Kind of record
- Journal article
How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
- Starts at High
- Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
- Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
- Ends at Low2 steps down.
- Checked, nothing to step it down for
- indirectness
- Inconsistency
- One study, so there was nothing to disagree
Imprecision stops at the first check that applies; others may apply too.
AI review could not confirm it — an AI agent re-read this finding against the saved source and at least one check failed. The batch record names the check and quotes the sentence that caused the doubt. No person read it.
What is still missing from these readings
- None gives a number at all, only which way it went.
- Two give no likely range, so how precise those numbers are is unknown.
- One do not say how many people took part.
Something nobody wrote down is never a zero and never a guess.
Still to read for Piperine
Five of the 17 things on our list for Piperine have no reading here yet:
- Atrial fibrillation incidence
- Carotid intima-media thickness (CIMT)
- Fibrinogen
- Oxidative stress (F2-isoprostanes)
- Total testosterone
Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.
Read next
Piperine
11 other questions read for it
Heart and blood pressure
49 questions read under it
Systolic blood pressure
15 other ingredients read against it
First six, alphabetical, and by nothing else. The rest are on Heart and blood pressure.
This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.